Skip to content
Inspirata Boosts Its Open Architecture Promise by Launching an Extensive Approved Partner Program
Recognizing how impractical and commercially undesirable locking customers into exclusive solutions can be, Inspirata has collaborated with a diverse array of category leaders to allow healthcare providers a true choice in laboratory and diagnostic technologies.



Tampa, Florida, March 17, 2020 / GlobeNewswire – True to its promise of building an open platform in digital pathology, Inspirata announced today its extensive Approved Partner Program. Initially starting with four critical areas in laboratory and diagnostic technologies – namely, Whole Slide Image (WSI) Scanning, AP-LIS/LIMS, Image Analysis Solutions, and Non-Scanner Imaging, the software solutions provider plans to expand this program to Cancer Informatics and other related areas.

Mark Lloyd, PhD, EVP and Founder of Inspirata, is very optimistic about the future of the Approved Partner Program saying, “it is exciting to see so many global category leaders who share our commitment to open standards, solution interoperability and stakeholder collaboration. Having this formal program gives our existing and future customers the confidence they will continue to have access to the best laboratory technologies, including the latest in artificial intelligence, when they go digital.”

The “open-platform” sentiment is strong among all partners who have formally joined Inspirata’s program.

“We are pleased to have found a partner with whom we are truly removing barriers to digital pathology,” says Janne Haavisto, CTO at WSI scanner vendor Grundium.

“The partnership with Inspirata stems from our shared passion to see digital pathology genuinely help clinicians. Combining our technologies is a thrilling prospect for the future of pathology,” chimes in Gabe Siegel, CEO of Augmentiqs, a provider of augmented reality (AR) in healthcare.

The new program’s dedicated page on Inspirata’s web site features datasheets for dozens of technical integrations. Visit or email us at for more details.


About Inspirata

Inspirata, Inc. helps patients fighting cancer—and the clinicians they trust—to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.

Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring users the broadest oncology informatics platform available globally.


Inspirata Contact:

Emil Mladenov, Vice President of Corporate and Digital Marketing
E-mail: | Tel: +1-813-467-7616

Inspirata Joins Advarra’s New API Partner Program as an Inaugural Member

Inspirata Joins Advarra’s New API...

As new partners, Inspirata and Advarra will collaborate on ensuring integrations between Inspirata's Trial Navigator and Advarra's OnCore.
Inspirata Receives Industry’s First FDA Clearance for Scanner Agnostic Digital Pathology Software

Inspirata Receives Industry’s First FDA...

Inspirata is proud to announce that Dynamyx now holds the industry's first FDA clearance for digital pathology software with multiple…
NHS Cancer Alliance Implements Inspirata AI to Improve Clinical Trial Access for South West Patients

NHS Cancer Alliance Implements Inspirata...

NHS Cancer Alliance Implements Inspirata AI to Improve Access to Clinical Trials Across Somerset, Wiltshire, Avon and Gloucestershire.